NUK - logo
E-viri
Recenzirano Odprti dostop
  • Prognostic assessment of st...
    Nielsen, Lene H; Bøtker, Hans Erik; Sørensen, Henrik T; Schmidt, Morten; Pedersen, Lars; Sand, Niels Peter; Jensen, Jesper M; Steffensen, Flemming H; Tilsted, Hans Henrik; Bøttcher, Morten; Diederichsen, Axel; Lambrechtsen, Jess; Kristensen, Lone D; Øvrehus, Kristian A; Mickley, Hans; Munkholm, Henrik; Gøtzsche, Ole; Husain, Majed; Knudsen, Lars L; Nørgaard, Bjarne L

    European heart journal, 02/2017, Letnik: 38, Številka: 6
    Journal Article

    To examine the 3.5 year prognosis of stable coronary artery disease (CAD) as assessed by coronary computed tomography angiography (CCTA) in real-world clinical practice, overall and within subgroups of patients according to age, sex, and comorbidity. This cohort study included 16,949 patients (median age 57 years; 57% women) with new-onset symptoms suggestive of CAD, who underwent CCTA between January 2008 and December 2012. The endpoint was a composite of late coronary revascularization procedure >90 days after CCTA, myocardial infarction, and all-cause death. The Kaplan-Meier estimator was used to compute 91 day to 3.5 year risk according to the CAD severity. Comparisons between patients with and without CAD were based on Cox-regression adjusted for age, sex, comorbidity, cardiovascular risk factors, concomitant cardiac medications, and post-CCTA treatment within 90 days. The composite endpoint occurred in 486 patients. Risk of the composite endpoint was 1.5% for patients without CAD, 6.8% for obstructive CAD, and 15% for three-vessel/left main disease. Compared with patients without CAD, higher relative risk of the composite endpoint was observed for non-obstructive CAD hazard ratio (HR): 1.28; 95% confidence interval (CI): 1.01-1.63, obstructive one-vessel CAD (HR: 1.83; 95% CI: 1.37-2.44), two-vessel CAD (HR: 2.97; 95% CI: 2.09-4.22), and three-vessel/left main CAD (HR: 4.41; 95% CI :2.90-6.69). The results were consistent in strata of age, sex, and comorbidity. Coronary artery disease determined by CCTA in real-world practice predicts the 3.5 year composite risk of late revascularization, myocardial infarction, and all-cause death across different groups of age, sex, or comorbidity burden.